Pfizer acquires clinical-stage biotech Therachon

This article was originally published here

Under the terms of the agreement, Pfizer will acquire Therachon for $340m upfront with an additional $470m in additional payments contingent on the achievement of key milestones in

The post Pfizer acquires clinical-stage biotech Therachon appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply